Moreover, tumor mutation burden was positively correlated with CD8 T cells (Fig. S11B; Fig. 4E), and the prognosis of patients with MSI-L and MSI-H status was poorer than that of patients with MSS, who also had a lower AMI value (Fig. 4G; Fig. S11F-G). The gene discussed is CD8A; the disease is neoplasm.